Undisclosed Immunotherapy Program(s)

About Abacus Bioscience

Abacus Bioscience is a private, preclinical-stage biotech focused on pioneering active immunotherapies that break immune tolerance, a significant barrier in treating cancer and persistent infections. Leveraging advanced computational tools like AlphaFold for drug design, the company is building a pipeline of novel biologics. Operating from the major biotech hub of San Diego, it is positioned to tackle large, underserved markets in oncology and infectious diseases, though it remains an early-stage, pre-revenue venture.

Therapeutic Areas